Retaglutide is a novel GLP-1 receptor agonist currently under study for the control of obesity. This therapy works by stimulating the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone that https://darrenmzdi865502.blogmazing.com/37885242/trelaglutide-exploring-a-new-therapy-for-chronic-diseases